A detailed history of State Board Of Administration Of Florida Retirement System transactions in Supernus Pharmaceuticals, Inc. stock. As of the latest transaction made, State Board Of Administration Of Florida Retirement System holds 79,736 shares of SUPN stock, worth $2.84 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares
79,736
Previous 14,023 468.61%
Holding current value
$2.84 Million
Previous $375,000 562.93%
% of portfolio
0.0%
Previous 0.0%

Shares

29 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 08, 2024

BUY
$25.77 - $35.16 $1.69 Million - $2.31 Million
65,713 Added 468.61%
79,736 $2.49 Million
Q2 2024

Aug 08, 2024

SELL
$25.99 - $33.85 $913,210 - $1.19 Million
-35,137 Reduced 71.47%
14,023 $375,000
Q1 2024

May 08, 2024

BUY
$27.11 - $35.17 $952,564 - $1.24 Million
35,137 Added 250.57%
49,160 $1.68 Million
Q3 2023

Nov 08, 2023

SELL
$27.57 - $32.91 $878,848 - $1.05 Million
-31,877 Reduced 69.45%
14,023 $386,000
Q2 2023

Aug 11, 2023

SELL
$29.91 - $38.73 $97,506 - $126,259
-3,260 Reduced 6.63%
45,900 $1.38 Million
Q1 2023

Jun 14, 2023

SELL
$34.93 - $42.03 $602,891 - $725,437
-17,260 Reduced 25.99%
49,160 $1.78 Million
Q1 2023

May 11, 2023

SELL
$34.93 - $42.03 $602,891 - $725,437
-17,260 Reduced 25.99%
49,160 $1.78 Million
Q4 2022

Jun 14, 2023

BUY
$31.09 - $37.88 $536,613 - $653,808
17,260 Added 35.11%
66,420 $2.37 Million
Q4 2022

Feb 07, 2023

SELL
$31.09 - $37.88 $247,165 - $301,146
-7,950 Reduced 10.69%
66,420 $2.37 Million
Q3 2022

Nov 08, 2022

BUY
$28.79 - $35.41 $1.36 Million - $1.68 Million
47,332 Added 175.06%
74,370 $2.52 Million
Q2 2022

Aug 05, 2022

SELL
$25.33 - $34.25 $1.54 Million - $2.08 Million
-60,684 Reduced 69.18%
27,038 $782,000
Q1 2022

May 06, 2022

SELL
$28.51 - $32.9 $287,010 - $331,204
-10,067 Reduced 10.29%
87,722 $2.84 Million
Q4 2021

Feb 08, 2022

BUY
$26.37 - $34.22 $105,400 - $136,777
3,997 Added 4.26%
97,789 $2.85 Million
Q2 2021

Aug 10, 2021

SELL
$26.72 - $33.19 $119,171 - $148,027
-4,460 Reduced 4.54%
93,792 $2.89 Million
Q1 2021

May 10, 2021

BUY
$24.15 - $31.45 $155,526 - $202,538
6,440 Added 7.01%
98,252 $2.57 Million
Q4 2020

Feb 08, 2021

BUY
$17.7 - $25.81 $708,725 - $1.03 Million
40,041 Added 77.34%
91,812 $2.31 Million
Q3 2020

Nov 09, 2020

BUY
$20.2 - $25.05 $257,933 - $319,863
12,769 Added 32.74%
51,771 $1.08 Million
Q2 2020

Aug 07, 2020

BUY
$17.09 - $24.89 $227,228 - $330,937
13,296 Added 51.72%
39,002 $926,000
Q1 2020

May 05, 2020

SELL
$14.45 - $24.69 $641,580 - $1.1 Million
-44,400 Reduced 63.33%
25,706 $462,000
Q4 2019

Feb 03, 2020

SELL
$19.93 - $29.13 $2,790 - $4,078
-140 Reduced 0.2%
70,106 $1.66 Million
Q3 2019

Nov 07, 2019

SELL
$25.47 - $33.37 $28,449 - $37,274
-1,117 Reduced 1.57%
70,246 $1.93 Million
Q2 2019

Aug 05, 2019

BUY
$29.96 - $38.87 $4,194 - $5,441
140 Added 0.2%
71,363 $2.36 Million
Q1 2019

May 03, 2019

BUY
$32.77 - $41.99 $295,290 - $378,371
9,011 Added 14.48%
71,223 $2.5 Million
Q4 2018

Feb 01, 2019

SELL
$30.84 - $49.51 $76,051 - $122,091
-2,466 Reduced 3.81%
62,212 $2.07 Million
Q3 2018

Oct 31, 2018

BUY
$42.7 - $56.55 $246,720 - $326,745
5,778 Added 9.81%
64,678 $3.26 Million
Q2 2018

Aug 06, 2018

BUY
$44.1 - $59.85 $1.49 Million - $2.02 Million
33,764 Added 134.33%
58,900 $3.53 Million
Q1 2018

May 04, 2018

BUY
$37.15 - $46.9 $25,224 - $31,845
679 Added 2.78%
25,136 $1.15 Million
Q4 2017

Feb 01, 2018

BUY
$36.4 - $42.6 $28,392 - $33,228
780 Added 3.29%
24,457 $975,000
Q3 2017

Oct 31, 2017

BUY
$36.75 - $49.65 $870,129 - $1.18 Million
23,677
23,677 $947,000

Others Institutions Holding SUPN

About SUPERNUS PHARMACEUTICALS, INC.


  • Ticker SUPN
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Drug Manufacturers—Specialty & Generic
  • Shares Outstandng 53,495,300
  • Market Cap $1.9B
  • Description
  • Supernus Pharmaceuticals, Inc., a biopharmaceutical company, focuses on the development and commercialization of products for the treatment of central nervous system (CNS) diseases in the United States. Its commercial products are Trokendi XR, an extended release topiramate product indicated for the treatment of epilepsy, as well as for the prop...
More about SUPN
Track This Portfolio

Track State Board Of Administration Of Florida Retirement System Portfolio

Follow State Board Of Administration Of Florida Retirement System and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of State Board Of Administration Of Florida Retirement System, based on Form 13F filings with the SEC.

News

Stay updated on State Board Of Administration Of Florida Retirement System with notifications on news.